Clinical Trial Update: Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to Alcoholism [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ziprasidone for psychiatric symptoms associated with alcoholism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Anxiety Disorders
• Major Depressive Disorder

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Depression, Anger | Phase 3 | Status: COMPLETED